Renner E L
Institut für Klinische Pharmakologie, Universität Bern.
Schweiz Med Wochenschr. 1992 Apr 25;122(17):614-8.
Since most patients with an alcohol problem downplay their alcohol consumption, reliable tests for detection of alcohol abuse would be of value in clinical practice. Single determinations of common laboratory tests such as gamma-glutamyl transpeptidase, transaminases or mean corpuscular volume are only of limited reliability in detecting alcohol abuse. Most newer parameters, including the serum ASAT/ALAT ratio, the ratio of mitochondrial to total ASAT in serum, and serum levels of acetaldehyde-hemoglobin adducts or of antibodies against acetaldehyde adducts, still do not allow us to discriminate reliably enough between alcoholic and nonalcoholic liver diseases. beta-hexosaminidase activity and desialylated transferrin levels in serum appear to be the most promising tests for detecting alcohol abuse in the future. They require, however, additional validation and technical simplification respectively before they are suitable for daily clinical use. Thus, it remains valid that no single test can replace a careful history, clinical examination and laboratory results in detecting patients with alcohol problems.
由于大多数有酒精问题的患者会淡化自己的饮酒量,因此在临床实践中,可靠的酒精滥用检测方法将很有价值。单次测定常见实验室检查项目,如γ-谷氨酰转肽酶、转氨酶或平均红细胞体积,在检测酒精滥用方面的可靠性有限。大多数更新的指标,包括血清谷草转氨酶/谷丙转氨酶比值、血清中线粒体谷草转氨酶与总谷草转氨酶的比值,以及乙醛-血红蛋白加合物或抗乙醛加合物抗体的血清水平,仍然无法让我们足够可靠地区分酒精性肝病和非酒精性肝病。血清中的β-己糖胺酶活性和去唾液酸转铁蛋白水平似乎是未来检测酒精滥用最有前景的检查项目。然而,在它们适用于日常临床使用之前,分别需要进一步验证和技术简化。因此,在检测有酒精问题的患者时,没有任何单一检查能够取代详细的病史、临床检查和实验室检查结果,这一点仍然成立。